Evidence map›Paper›PMID 42135542›Full record

ArticleAnnals of surgical oncology2026

High-Volume Anesthesiologist and Surgeon Teams are Associated with Lower Operating Room Charges for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Yusuf Ciftci, Shannon N Radomski, Victor B Yang, Nolan M Winicki, Samir Al-Ali, Sean Love, Norman G Nicolson, Fabian M Johnston, Jonathan B Greer

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yusuf CiftciDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Shannon N RadomskiDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Victor B YangDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Nolan M WinickiDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Samir Al-AliDepartment of Anesthesiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sean LoveDepartment of Anesthesiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Norman G NicolsonDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Fabian M JohnstonDepartment of Surgery, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Jonathan B GreerDepartment of Surgery, Massachusetts General Hospital, Boston, MA, USA. jbgreer@mgb.org.ORCID http://orcid.org/0000-0001-8968-9710

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAnesthesiologist and surgeon experience are associated with improved outcomes and lower costs in various oncologic procedures. The role of the anesthesiologist-surgeon dyad on outcomes and charges for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) has not been studied.

methodsWe performed a retrospective cohort study of patients undergoing CRS-HIPEC at a single quaternary center from 2016 to 2023. High-volume anesthesiologists (ANES) and surgeons (SURG) were defined as those in the top quartile of cases for their respective position (ANES: 10 cases, SURG: 87 cases). The study cohort was then divided into four subcohorts based on anesthesiologist and surgeon volume: low-volume anesthesiologist and surgeon (LALS), high-volume anesthesiologist and low-volume surgeon (HALS), low-volume anesthesiologist and high-volume surgeon (LAHS), and high-volume anesthesiologist and surgeon (HAHS).

resultsThe study cohort consisted of 237 patients undergoing CRS-HIPEC from 2016 to 2023. Median age was 59 years (interquartile range 48-66). Most patients were female (n = 135, 57%), White (n = 174, 73%), and privately insured (n = 134, 57%). The HAHS cohort had the lowest median total ($99,921, p = 0.603), operating room ($33,560, p = 0.266), and other ($11,384, p = 0.437) charges compared with the other cohorts. After adjusting for patient complexity, the HAHS cohort had significantly lower operating room charges (estimate -$5784, 95% confidence interval [-$11,076 to -$491], p = 0.032), length of stay (- 4.77 days, [- 9.04 to - 0.51 days], p = 0.029), and odds of delayed extubation (odds ratio 0.79, 95% confidence interval [0.65-0.98], p = 0.029) compared with the LALS cohort.

conclusionsThe HAHS teams are associated with significantly lower operating room charges, length of stay, and delayed extubation compared with LALS teams in CRS-HIPEC.

Indexed as

AnesthesiologistsCytoreduction Surgical ProceduresHyperthermic Intraperitoneal ChemotherapyOperating RoomsPatient Care TeamPeritoneal NeoplasmsSurgeonsAgedCombined Modality TherapyFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisRetrospective StudiesAnesthesiologist-Surgeon DyadsCostCRS-HIPECHealth SystemsSurgical Outcomes

Identifiers

PMID42135542

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.